Loading Events

« All Events

FOTIVDA®(tivozanib) Efficacy, Safety, and Use for Adult Patients With Relapsed or Refractory Advanced Renal Cell Carcinoma (rrRCC) Following 2 or More Prior Systemic Therapies

August 25 @ 5:30 pm - 6:30 pm

FOTIVDA®(tivozanib) Efficacy, Safety, and Use for Adult Patients With Relapsed or Refractory Advanced Renal Cell Carcinoma (rrRCC) Following 2 or More Prior Systemic Therapies.

Read More & Register! 

 

This meeting is being sponsored by:

Details

Date:
August 25
Time:
5:30 pm - 6:30 pm
Event Category:

Venue

Webinar
Website:
moasc@moasc.org

Organizer

MOASC
Phone:
909-985-9061
Email:
moasc@moasc.org
Website:
www.moasc.org